- Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to
![](https://www.hilltimes.com/wp-content/uploads/2024/02/medications-257336_1280-e1708466787154.jpg)
- Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to
- Displacing comprehensive employer-sponsored drug plans with a single-payer universal pharmacare model would have adverse consequences, including reduced coverage, lost tax revenue, slower access to
![](https://www.hilltimes.com/wp-content/uploads/2024/02/medications-257336_1280-e1708466787154-1024x512.jpg)